Yong-Gang DUAN

Dr. Yong-Gang DUAN

The University of Hong Kong - ShenZhen Hospital
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JGJialei Gong
Jialei Gong
QZQunxiong Zeng
Qunxiong Zeng
DYDi Yu
Di Yu
YDYong-Gang DUAN
Yong-Gang DUAN
The immune privilege of the testes is necessary to prevent immune attacks to gamete-specific antigens and paternal major histocompatibility complex (MHC) antigens, allowing for normal spermatogenesis. However, infection and inflammation of the male genital tract can break the immune tolerance and represent a significant cause of male infertility. Different T cell subsets have been identified in mammalian testes, which may be involved in the maintenance of immune tolerance and pathogenic immune responses in testicular infection and inflammation. We reviewed the evidence in the published literature on different T subtypes (regulatory T cells, helper T cells, cytotoxic T cells, γδ T cells, and natural killer T cells) in human and animal testes that support their regulatory roles in infertility and the orchitis pathology. While many in vitro studies have indicated the regulation potential of functional T cell subsets and their possible interaction with Sertoli cells, Leydig cells, and spermatogenesis, both under physiological and pathological processes, there have been no in situ studies to date. Nevertheless, the normal distribution and function of T cell subsets are essential for the immune privilege of the testes and intact spermatogenesis, and T cell-mediated immune response drives testicular inflammation. The distinct function of different T cell subsets in testicular homeostasis and the orchitis pathology suggests a considerable potential of targeting specific T cell subsets for therapies targeting chronic orchitis and immune infertility.

6 June 2017 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
Tao ZhangTao Zhang
Tao Zhang
FTFuying Tian
Fuying Tian
RHRan Huo
Ran Huo
ATAifa Tang
Aifa Tang
YZYong Zeng
Yong Zeng
YDYong-Gang DUAN
Yong-Gang DUAN

15 June 2023 in Andrology
Verified
Journal Article
Closed access
TWTingting Wang
Tingting Wang
QWQiling Wang
Qiling Wang
ZFZhaoyu Fan
Zhaoyu Fan
RXRuijun Xu
Ruijun Xu
XDXinyi Deng
Xinyi Deng
Yuewei LiuYuewei Liu
Yuewei Liu

3 November 2023 in Science Advances
Verified
Journal Article
Open access
QZQingqing Zhang
Qingqing Zhang
CLCheuk-Lun Lee
Cheuk-Lun Lee
TYTingyu Yang
Tingyu Yang
JLJianlin Li
Jianlin Li
QZQunxiong Zeng
Qunxiong Zeng
PCPhilip C.N. Chiu
Philip C.N. Chiu
Early-onset preeclampsia (EOPE) is a severe pregnancy complication associated with defective trophoblast differentiation and functions at implantation, but manifestation of its phenotypes is in late pregnancy. There is no reliable method for early prediction and treatment of EOPE. Adrenomedullin (ADM) is an abundant placental peptide in early pregnancy. Integrated single-cell sequencing and spatial transcriptomics confirm a high ADM expression in the human villous cytotrophoblast and syncytiotrophoblast. The levels of ADM in chorionic villi and serum were lower in first-trimester pregnant women who later developed EOPE than those with normotensive pregnancy. ADM stimulates differentiation of trophoblast stem cells and trophoblast organoids in vitro. In pregnant mice, placenta-specific ADM suppression led to EOPE-like phenotypes. The EOPE-like phenotypes in a mouse PE model were reduced by a placenta-specific nanoparticle-based forced expression of ADM. Our study reveals the roles of trophoblastic ADM in placental development, EOPE pathogenesis, and its potential clinical uses.

5 June 2019 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
RDRuiying Diao
Ruiying Diao
HGHuimei Gan
Huimei Gan
FTFuying Tian
Fuying Tian
XCXueyong Cai
Xueyong Cai
WZWanhua Zhen
Wanhua Zhen
YDYong-Gang DUAN
Yong-Gang DUAN

2 December 2022 in Andrology
Verified
Journal Article
Closed access
CYChen Yang
Chen Yang
QZQun‐Xiong Zeng
Qun‐Xiong Zeng
JLJin‐Chuan Liu
Jin‐Chuan Liu
WYWilliam Shu‐Biu Yeung
William Shu‐Biu Yeung
JZJian V. Zhang
Jian V. Zhang
YDYong-Gang DUAN
Yong-Gang DUAN